Resources in question as TGA modernises
Most areas of the pharmaceutical sector appear to agree that modernising the TGA is a good thing but how much pressure the new requirements will place on the regulator's resources remains an issue.
Roche's new lung cancer drug approved
Roche's Alecensa has been approved for second-line treatment of ALK-positive advanced or metastatic NSCLC after Pfizer's Xalkori while Galderma has registered a higher dose form of acne treatment Epiduo.
Pharma sales reps' future - the next five years
Pharma is very good at training and deploying sales people in the field to sell brands. It's a model that has worked for many years. It's also one that's often said to be under threat, but is it really?